Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Laurent Castera

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Journal of Hepatology|March 28, 2024
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetesLaurent Castera, Philippe Garteiser, Cédric Laouenan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2020
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysisMaja Thiele, Mie B Hugger, Yongsoo Kim, et al.
Ultrasound in Medicine & Biology|April 24, 2024
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat QuantificationGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Cell Death and Differentiation|November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver diseaseOmar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Ultrasound in Medicine & Biology|May 18, 2024
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound ElastographyGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
The Lancet Regional Health. Europe|July 17, 2025
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitisJeffrey V Lazarus, Paul N Brennan, Henry E Mark, et al.
Journal of Hepatology|May 24, 2024
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithmsMargarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, et al.
BMC Cancer|March 6, 2019
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocolPaul Lesueur, Justine Lequesne, Jean-Michel Grellard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2021
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the PopulationIsabel Graupera, Maja Thiele, Miquel Serra-Burriel, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Journal of Hepatology|March 28, 2024
Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetesLaurent Castera, Philippe Garteiser, Cédric Laouenan, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|March 18, 2020
2D shear wave liver elastography by Aixplorer to detect portal hypertension in cirrhosis: An individual patient data meta-analysisMaja Thiele, Mie B Hugger, Yongsoo Kim, et al.
Ultrasound in Medicine & Biology|April 24, 2024
WFUMB Guidelines/Guidance on Liver Multiparametric Ultrasound. Part 2: Guidance on Liver Fat QuantificationGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
Hepatology (Baltimore, Md.)|October 24, 2017
Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory scienceMohammad Shadab Siddiqui, Stephen A Harrison, Manal F Abdelmalek, et al.
Cell Death and Differentiation|November 16, 2024
ACBP/DBI neutralization for the experimental treatment of fatty liver diseaseOmar Motiño, Flavia Lambertucci, Adrien Joseph, et al.
Ultrasound in Medicine & Biology|May 18, 2024
WFUMB Guideline/Guidance on Liver Multiparametric Ultrasound: Part 1. Update to 2018 Guidelines on Liver Ultrasound ElastographyGiovanna Ferraioli, Richard Gary Barr, Annalisa Berzigotti, et al.
The Lancet Regional Health. Europe|July 17, 2025
A call for doubling the diagnostic rate of at-risk metabolic dysfunction-associated steatohepatitisJeffrey V Lazarus, Paul N Brennan, Henry E Mark, et al.
Journal of Hepatology|May 24, 2024
Agile scores in MASLD and ALD: External validation and their utility in clinical algorithmsMargarita Papatheodoridi, Victor De Ledinghen, Monica Lupsor-Platon, et al.
BMC Cancer|March 6, 2019
Phase I/IIa study of concomitant radiotherapy with olaparib and temozolomide in unresectable or partially resectable glioblastoma: OLA-TMZ-RTE-01 trial protocolPaul Lesueur, Justine Lequesne, Jean-Michel Grellard, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|December 31, 2021
Low Accuracy of FIB-4 and NAFLD Fibrosis Scores for Screening for Liver Fibrosis in the PopulationIsabel Graupera, Maja Thiele, Miquel Serra-Burriel, et al.
Pageof 21